GT
OXFD

Glenmede Trust’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Glenmede Trust’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-80
Closed – – 2539
2020
Q3 		$0 Hold
80
– – ﹤0.01% 2652
2020
Q2 		$1K Buy
+80
New +$961 ﹤0.01% 2420
2019
Q3 		– Sell
-662
Closed -$9 – 3176
2019
Q2 		$9 Buy
+662
New +$10.1K ﹤0.01% 2440
2017
Q3 		– Sell
-95
Closed -$1K – 2889
2017
Q2 		$1K Hold
95
– – ﹤0.01% 2622
2017
Q1 		$1K Buy
+95
New +$1.36K ﹤0.01% 2622

Other funds holding OXFD

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Glenmede Trust's OXFD Position: Q4 2020 in Review

Glenmede Trust sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q4 2020, closing a stake of 80 shares.

Glenmede Trust first reported a position in OXFD in Q1 2017 and held it in 5 quarters. The position peaked at $1K in Q2 2020. 60 funds tracked by Wall St. Rank hold OXFD as of Q4 2020.

  • Glenmede Trust reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q4 2020 after selling out during the quarter.
  • Glenmede Trust sold 80 Oxford Immunotec Global PLC Ordinary Shares shares in Q4 2020.
  • Glenmede Trust first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q1 2017 and held it in 5 quarters.
  • Glenmede Trust's Oxford Immunotec Global PLC Ordinary Shares position peaked at $1K in Q2 2020.
  • 60 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.